NCT06680492 The Role of Nutrition in Muscle Function of Bariatric Surgery Patients
| NCT ID | NCT06680492 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Concordia University, Montreal |
| Condition | Obesity, Diabetes, Nutrition, Physical Health |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2017-06-23 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2017-06-23 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Current recommendations for protein intake after bariatric surgery are not based on strong scientific evidence. It remains unclear how much protein should be eaten to minimize muscle loss and preserve the metabolism and function of individuals post-bariatric surgery. The objective of this study is to analyze the relationships between changes in body composition, nutrition and protein intake, and muscle function after bariatric surgery to further our understanding of the nutritional needs of patients after bariatric surgery. We intend to recruit around 75 participants, men and women, aged between 18 and 65 years. Participants will be recruited from the Bariatric Surgery Clinic, McGill University Health Center.
Eligibility Criteria
Inclusion Criteria: * Male and female * Aged 18 to 65 years old * Undergoing first bariatric surgery (any type) * Diabetics and non-diabetics * Non-smokers and non-cannabis consumers Exclusion Criteria: * Pregnant and breastfeeding women * Individuals undergoing second bariatric surgery * Regular smokers and cannabis consumers * Current use of Ozempic (or Ozempic-like medication) and anti-psychotic meds * Limited physical mobility (using walking aids such as canes, walkers, or wheelchairs) and issues with hand resistance * Kidney disease, non-controlled / unstable hypertension and hypothyroidism, and any metabolic disease other than diabetes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06680492 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity, Diabetes, Nutrition, Physical Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06680492 currently recruiting?
Yes, NCT06680492 is actively recruiting participants. Contact the research team at s.santosa@concordia.ca for enrollment information.
Where is the NCT06680492 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06680492 clinical trial?
NCT06680492 is sponsored by Concordia University, Montreal. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.